Search Results - Laban Kato

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Prevalence and Characterization of Carbapenem-Resistant Enterobacteriaceae Isolated from Mulago National Referral Hospital, Uganda. by Deogratius Okoche, Benon B Asiimwe, Fred Ashaba Katabazi, Laban Kato, Christine F Najjuka

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  2. 2

    Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort by Gerald Kevin Oluka, Jackson Sembera, Joseph Ssebwana Katende, Violet Ankunda, Laban Kato, Ashwini Kurshan, Carl Graham, Jeffrey Seow, Katie J. Doores, Michael H. Malim, Julie M. Fox, Pontiano Kaleebu, Jennifer Serwanga

    Published in Vaccines (2025-01-01)
    Get full text
    Article


  3. 3

    Subtype AD Recombinant HIV-1 Transmitted/Founder Viruses Are Less Sensitive to Type I Interferons than Subtype D by Denis Omara, Fortunate Natwijuka, Anne Kapaata, Frank Kato, Laban Kato, Christian Ndekezi, Angella Nakyanzi, Mercy L. Ayebale, Ling Yue, Eric Hunter, Obondo J. Sande, Christina Ochsenbauer, Pontiano Kaleebu, Sheila N. Balinda

    Published in Viruses (2025-03-01)
    Get full text
    Article


  4. 4

    Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles. by Jennifer Serwanga, Gerald Kevin Oluka, Claire Baine, Violet Ankunda, Jackson Sembera, Laban Kato, Joseph Ssebwana Katende, Geoffrey Odoch, Betty Oliver Auma, Ben Gombe, COVID-19 Immunoprofiling Team, Monica Musenero, Pontiano Kaleebu

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  5. 5

    Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK–Uganda Comparison by Laban Kato, Jackson Sembera, Gerald Kevin Oluka, Joseph Ssebwana Katende, Juliana Bemanzi, Violet Ankunda, Peter Ejou, Ashwini Kurshan, Carl Graham, Jeffrey Seow, Katie J. Doores, Michael H. Malim, Julie M. Fox, Pontiano Kaleebu, Jennifer Serwanga

    Published in Vaccines (2025-03-01)
    Get full text
    Article


  6. 6

    Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan... by Jonathan Kitonsa, Jennifer Serwanga, Hannah M. Cheeseman, Andrew Abaasa, Jane Frances Lunkuse, Eugene Ruzagira, Laban Kato, Florence Nambaziira, Gerald Kevin Oluka, Ben Gombe, Sembera Jackson, Joseph Katende Ssebwana, Leon R. McFarlane, Sarah Joseph, Benjamin F. Pierce, Robin J. Shattock, Pontiano Kaleebu

    Published in Vaccines (2025-05-01)
    Get full text
    Article


  7. 7

    The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort by Jennifer Serwanga, Jennifer Serwanga, Laban Kato, Gerald Kevin Oluka, Gerald Kevin Oluka, Violet Ankunda, Jackson Sembera, Claire Baine, Isaac Kitabye, Angela Namuyanja, Solomon Opio, Joseph Ssebwana Katende, Joseph Ssebwana Katende, Peter Ejou, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Pontiano Kaleebu, Pontiano Kaleebu

    Published in Frontiers in Immunology (2024-05-01)
    Get full text
    Article


  8. 8

    Spike protein is a key target for stronger and more persistent T-cell responses—a study of mild and asymptomatic SARS-CoV-2 infection by Ivan Ssali, Susan Mugaba, Arthur Kalyebi Watelo, Juliana Bemanzi, Joseph Ssebwana Katende, Gerald Kevin Oluka, Violet Ankunda, Claire Baine, Laban Kato, Nathan Onyachi, Moses Muwanga, Mark Jjuuko, John Kayiwa, Christopher Nsereko, Betty Oliver Auma, Daniela Weiskopf, Alessandro Sette, Tom Lutalo, Monica Musenero, Pontiano Kaleebu, Jennifer Serwanga

    Get full text
    Article


  9. 9

    Sustained spike-specific IgG antibodies following CoronaVac (Sinovac) vaccination in sub-Saharan Africa, but increased breakthrough infections in baseline spike-naive individuals by Jackson Sembera, Claire Baine, Violet Ankunda, Joseph Ssebwana Katende, Joseph Ssebwana Katende, Gerald Kevin Oluka, Gerald Kevin Oluka, Christine Hermilia Akoli, Laban Kato, Geoffrey Odoch, Peter Ejou, Solomon Opio, Monica Musenero, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Pontiano Kaleebu, Pontiano Kaleebu, Jennifer Serwanga, Jennifer Serwanga

    Published in Frontiers in Immunology (2023-11-01)
    Get full text
    Article


  10. 10

    Sustained S-IgG and S-IgA antibodies to Moderna’s mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations by Jennifer Serwanga, Jennifer Serwanga, Violet Ankunda, Joseph Ssebwana Katende, Joseph Ssebwana Katende, Claire Baine, Gerald Kevin Oluka, Gerald Kevin Oluka, Geoffrey Odoch, Hellen Nantambi, Susan Mugaba, Angella Namuyanja, Ivan Ssali, Peter Ejou, Laban Kato, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Monica Musenero, Pontiano Kaleebu, Pontiano Kaleebu, Jackson Sembera, Betty Oliver Auma, Solomon Opio, Ben Gombe

    Published in Frontiers in Immunology (2024-01-01)
    Get full text
    Article


  11. 11

    The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies by Violet Ankunda, Joseph Ssebwana Katende, Joseph Ssebwana Katende, Gerald Kevin Oluka, Gerald Kevin Oluka, Jackson Sembera, Claire Baine, Geoffrey Odoch, Peter Ejou, Laban Kato, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Pontiano Kaleebu, Pontiano Kaleebu, Jennifer Serwanga, Jennifer Serwanga, Christine Hermilia Akoli, Angela Namuyanja, Solomon Opio, Arthur Watelo Kalyebi, Ivan Ssali, Ben Gombe, Susan Mugaba, Hellen Nantambi

    Published in Frontiers in Immunology (2024-02-01)
    Get full text
    Article


  12. 12

    Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda by Gerald Kevin Oluka, Gerald Kevin Oluka, Patricia Namubiru, Laban Kato, Violet Ankunda, Ben Gombe, Matthew Cotten, Matthew Cotten, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Monica Musenero, Pontiano Kaleebu, Pontiano Kaleebu, Julie Fox, Jennifer Serwanga, Jennifer Serwanga, Claire Baine, Jackson Sembera, Susan Mugaba, Christine Hermilia Akoli, Geoffrey Odoch, Deus Mwesigwa, Peter Ejou, Joseph Ssebwana Katende

    Published in Frontiers in Immunology (2023-03-01)
    Get full text
    Article


  13. 13

    Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy by Jennifer Serwanga, Jennifer Serwanga, Claire Baine, Susan Mugaba, Violet Ankunda, Betty Oliver Auma, Gerald Kevin Oluka, Gerald Kevin Oluka, Laban Kato, Isaac Kitabye, Jackson Sembera, Geoffrey Odoch, Peter Ejou, Amina Nalumansi, Ben Gombe, Monica Musenero, Pontiano Kaleebu, Pontiano Kaleebu, the COVID-19 Immunoprofiling Team, the COVID-19 Immunoprofiling Team, Christine Hermilia Akoli, Deus Mwesigwa, Ivan Ssali, Hellen Nantambi, Angela Namuyanja, Solomon Opio, Arthur Watelo Kalyebi, Joseph Ssebwana Katende

    Published in Frontiers in Immunology (2023-05-01)
    Get full text
    Article


  14. 14

    Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens by Hellen Nantambi, Hellen Nantambi, Hellen Nantambi, Jackson Sembera, Jackson Sembera, Violet Ankunda, Ivan Ssali, Arthur Watelo Kalyebi, Arthur Watelo Kalyebi, Gerald Kevin Oluka, Gerald Kevin Oluka, Laban Kato, Bahemuka Ubaldo, Freddie Kibengo, Joseph Ssebwana Katende, Joseph Ssebwana Katende, Ben Gombe, Claire Baine, Geoffrey Odoch, Susan Mugaba, Obondo James Sande, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Pontiano Kaleebu, Pontiano Kaleebu, Jennifer Serwanga, Jennifer Serwanga

    Published in Frontiers in Immunology (2023-04-01)
    Get full text
    Article


Search Tools: